Cellyan Biotechnology Co., Ltd Nonderivative Financial Liabilities Undiscounted Cash Flows
Cellyan Biotechnology Co., Ltd (HKPD) had Nonderivative Financial Liabilities Undiscounted Cash Flows of $3.96 million as of 2025-09-30, per its 6-K filed 2026-03-18.
Financial Statements › Notes
ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows · last filed 2026-03-18
- 2025-09-30: Nonderivative Financial Liabilities Undiscounted Cash Flows $3.96M.
- 2025-03-31: Nonderivative Financial Liabilities Undiscounted Cash Flows $4.43M.
| Period end | Nonderivative Financial Liabilities Undiscounted Cash Flows |
|---|---|
| 2025-09-30 | $3.96M 6-K · filed 2026-03-18 |
| 2025-03-31 | $4.43M 20-F · filed 2025-08-14 |